A citation-based method for searching scientific literature

C Begg, M Cho, S Eastwood, R Horton, D Moher, I Olkin, R Pitkin, D Rennie, K F Schulz, D Simel, D F Stroup. JAMA 1996
Times Cited: 2502







List of co-cited articles
331 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
13

Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.
Tammy C Hoffmann, Paul P Glasziou, Isabelle Boutron, Ruairidh Milne, Rafael Perera, David Moher, Douglas G Altman, Virginia Barbour, Helen Macdonald, Marie Johnston,[...]. BMJ 2014
11


Reducing waste from incomplete or unusable reports of biomedical research.
Paul Glasziou, Douglas G Altman, Patrick Bossuyt, Isabelle Boutron, Mike Clarke, Steven Julious, Susan Michie, David Moher, Elizabeth Wager. Lancet 2014
632
9


SPIRIT 2013 statement: defining standard protocol items for clinical trials.
An-Wen Chan, Jennifer M Tetzlaff, Douglas G Altman, Andreas Laupacis, Peter C Gøtzsche, Karmela Krleža-Jerić, Asbjørn Hróbjartsson, Howard Mann, Kay Dickersin, Jesse A Berlin,[...]. Ann Intern Med 2013
8

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
David Moher, Sally Hopewell, Kenneth F Schulz, Victor Montori, Peter C Gøtzsche, P J Devereaux, Diana Elbourne, Matthias Egger, Douglas G Altman. BMJ 2010
8

CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.
Isabelle Boutron, Douglas G Altman, David Moher, Kenneth F Schulz, Philippe Ravaud. Ann Intern Med 2017
393
8

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
7

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
D Moher, B Pham, A Jones, D J Cook, A R Jadad, M Moher, P Tugwell, T P Klassen. Lancet 1998
7


A systematic scoping review of adherence to reporting guidelines in health care literature.
Zainab Samaan, Lawrence Mbuagbaw, Daisy Kosa, Victoria Borg Debono, Rejane Dillenburg, Shiyuan Zhang, Vincent Fruci, Brittany Dennis, Monica Bawor, Lehana Thabane. J Multidiscip Healthc 2013
99
7


Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
6

Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review.
Amy C Plint, David Moher, Andra Morrison, Kenneth Schulz, Douglas G Altman, Catherine Hill, Isabelle Gaboury. Med J Aust 2006
552
6

The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed.
Sally Hopewell, Susan Dutton, Ly-Mee Yu, An-Wen Chan, Douglas G Altman. BMJ 2010
331
6

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
Kenneth F Schulz, Douglas G Altman, David Moher. Ann Intern Med 2010
6

Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
Lucy Turner, Larissa Shamseer, Douglas G Altman, Laura Weeks, Jodi Peters, Thilo Kober, Sofia Dias, Kenneth F Schulz, Amy C Plint, David Moher. Cochrane Database Syst Rev 2012
408
6

The revised CONSORT statement for reporting randomized trials: explanation and elaboration.
D G Altman, K F Schulz, D Moher, M Egger, F Davidoff, D Elbourne, P C Gøtzsche, T Lang. Ann Intern Med 2001
6

Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study.
Agnes Dechartres, Ludovic Trinquart, Ignacio Atal, David Moher, Kay Dickersin, Isabelle Boutron, Elodie Perrodeau, Douglas G Altman, Philippe Ravaud. BMJ 2017
63
9

Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
Isabelle Boutron, David Moher, Douglas G Altman, Kenneth F Schulz, Philippe Ravaud. Ann Intern Med 2008
6

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
5


Guidance for developers of health research reporting guidelines.
David Moher, Kenneth F Schulz, Iveta Simera, Douglas G Altman. PLoS Med 2010
536
5


Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.
Karel G M Moons, Douglas G Altman, Johannes B Reitsma, John P A Ioannidis, Petra Macaskill, Ewout W Steyerberg, Andrew J Vickers, David F Ransohoff, Gary S Collins. Ann Intern Med 2015
5

Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
4

Assessing the quality of reports of randomized clinical trials: is blinding necessary?
A R Jadad, R A Moore, D Carroll, C Jenkinson, D J Reynolds, D J Gavaghan, H J McQuay. Control Clin Trials 1996
4

Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.
Melanie Calvert, Jane Blazeby, Douglas G Altman, Dennis A Revicki, David Moher, Michael D Brundage. JAMA 2013
598
4

Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement.
Hugh MacPherson, Douglas G Altman, Richard Hammerschlag, Li Youping, Wu Taixiang, Adrian White, David Moher. PLoS Med 2010
379
4

Better reporting of harms in randomized trials: an extension of the CONSORT statement.
John P A Ioannidis, Stephen J W Evans, Peter C Gøtzsche, Robert T O'Neill, Douglas G Altman, Kenneth Schulz, David Moher. Ann Intern Med 2004
903
4


Quality of reporting of randomized trials as a measure of methodologic quality.
Karin Huwiler-Müntener, Peter Jüni, Christoph Junker, Matthias Egger. JAMA 2002
299
4

Quality of Randomized Controlled Trials Reporting in the Treatment of Adult Patients with High-Grade Gliomas.
Magalie P Tardy, Jocelyn Gal, Emmanuel Chamorey, Fabien Almairac, Fanny Vandenbos, Pierre-Yves Bondiau, Esma Saada-Bouzid. Oncologist 2018
5
80


How to increase value and reduce waste when research priorities are set.
Iain Chalmers, Michael B Bracken, Ben Djulbegovic, Silvio Garattini, Jonathan Grant, A Metin Gülmezoglu, David W Howells, John P A Ioannidis, Sandy Oliver. Lancet 2014
664
4




Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.
Carol Kilkenny, William J Browne, Innes C Cuthill, Michael Emerson, Douglas G Altman. PLoS Biol 2010
4

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
4

Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review.
Julien Péron, Gregory R Pond, Hui K Gan, Eric X Chen, Roula Almufti, Denis Maillet, Benoit You. J Natl Cancer Inst 2012
70
5

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
3

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.
An-Wen Chan, Jennifer M Tetzlaff, Peter C Gøtzsche, Douglas G Altman, Howard Mann, Jesse A Berlin, Kay Dickersin, Asbjørn Hróbjartsson, Kenneth F Schulz, Wendy R Parulekar,[...]. BMJ 2013
3

Increasing value and reducing waste: addressing inaccessible research.
An-Wen Chan, Fujian Song, Andrew Vickers, Tom Jefferson, Kay Dickersin, Peter C Gøtzsche, Harlan M Krumholz, Davina Ghersi, H Bart van der Worp. Lancet 2014
410
3

Consort 2010 statement: extension to cluster randomised trials.
Marion K Campbell, Gilda Piaggio, Diana R Elbourne, Douglas G Altman. BMJ 2012
969
3

Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network.
Iveta Simera, David Moher, Allison Hirst, John Hoey, Kenneth F Schulz, Douglas G Altman. BMC Med 2010
221
3

Reporting of sample size calculation in randomised controlled trials: review.
Pierre Charles, Bruno Giraudeau, Agnes Dechartres, Gabriel Baron, Philippe Ravaud. BMJ 2009
155
3

EQUATOR: reporting guidelines for health research.
Douglas G Altman, Iveta Simera, John Hoey, David Moher, Ken Schulz. Lancet 2008
131
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.